| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comment on “Association of physical activity, including amount and maintenance, with the risk of HCC among patients with type 2 diabetes”
|
Gao, Ziwei
|
|
|
7 |
4 |
p.
|
artikel
|
| 2 |
Contents
|
|
|
|
7 |
4 |
p.
|
artikel
|
| 3 |
Copyright and information
|
|
|
|
7 |
4 |
p.
|
artikel
|
| 4 |
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I
|
Chen, Tong
|
|
|
7 |
4 |
p.
|
artikel
|
| 5 |
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis
|
Kornfehl, Andrea
|
|
|
7 |
4 |
p.
|
artikel
|
| 6 |
Diversity and inclusion in chronic hepatitis B randomised controlled trials: A systematic meta-epidemiological review
|
Huang, Xintong
|
|
|
7 |
4 |
p.
|
artikel
|
| 7 |
Editorial Board page
|
|
|
|
7 |
4 |
p.
|
artikel
|
| 8 |
Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial
|
Perez-Campuzano, Valeria
|
|
|
7 |
4 |
p.
|
artikel
|
| 9 |
Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver
|
Gjorgjieva, Monika
|
|
|
7 |
4 |
p.
|
artikel
|
| 10 |
Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcome
|
Sidali, Sabrina
|
|
|
7 |
4 |
p.
|
artikel
|
| 11 |
LAPTM4B enhances the stemness of CD133+ liver cancer stem-like cells via WNT/β-catenin signaling
|
Wang, Jiahong
|
|
|
7 |
4 |
p.
|
artikel
|
| 12 |
Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes
|
Shekhtman, Louis
|
|
|
7 |
4 |
p.
|
artikel
|
| 13 |
Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials
|
Fichez, Jeanne
|
|
|
7 |
4 |
p.
|
artikel
|
| 14 |
Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model
|
Wang, Cong
|
|
|
7 |
4 |
p.
|
artikel
|
| 15 |
Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trial
|
de Jong, Vivian
|
|
|
7 |
4 |
p.
|
artikel
|
| 16 |
Protective value of ischemia-free liver transplantation on post-transplant acute kidney injury
|
Zhao, Qiang
|
|
|
7 |
4 |
p.
|
artikel
|
| 17 |
Quality of life in patients with HBV infection: A systematic review and meta-analysis
|
Fu, Michael X.
|
|
|
7 |
4 |
p.
|
artikel
|
| 18 |
RAP1A suppresses hepatic steatosis by regulating amino acid-mediated mTORC1 activation
|
Agarwal, Heena
|
|
|
7 |
4 |
p.
|
artikel
|
| 19 |
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis
|
Di Giorgio, Angelo
|
|
|
7 |
4 |
p.
|
artikel
|
| 20 |
Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery
|
Santol, Jonas
|
|
|
7 |
4 |
p.
|
artikel
|
| 21 |
Statin use and liver-related prognosis among patients with MASLD
|
Yun, Byungyoon
|
|
|
7 |
4 |
p.
|
artikel
|
| 22 |
Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC
|
Lim, Jinyeong
|
|
|
7 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving